>DNA knows that there could be other suitors as well ala NVS, MRK, PFE, etc whose drugs are coming off patent and need cash cows to justify their paychecks.<
Other suitors would be surprising, IMO. Who would want to pay a large premium to the market price in order to be a minority shareholder?
Market Data 
Markets 
AI
